Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial

Goodwin, P. J., Dowling, R. J. O., Ennis, M., Chen, B. E., Parulekar, W. R., Shepherd, L. E., Burnell, M. J., Vander Meer, R., Molckovsky, A., Gurjal, A., Gelmon, K. A., Ligibel, J. A., Hershman, D. L., Mayer, I. A., Whelan, T. J., Hobday, T. J., Rastogi, P., Rabaglio-Poretti, M., Lemieux, J., … Stambolic, V. (2021). Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial. Npj Breast Cancer, 7(1). https://doi.org/10.1038/s41523-021-00275-z
Authors:
Pamela J. Goodwin
Ryan J. O. Dowling
Marguerite Ennis
Bingshu E. Chen
Wendy R. Parulekar
Lois E. Shepherd
Margot J. Burnell
Rachel Vander Meer
Andrea Molckovsky
Anagha Gurjal
Karen A. Gelmon
Jennifer A. Ligibel
Dawn L. Hershman
Ingrid A. Mayer
Timothy J. Whelan
Timothy J. Hobday
Priya Rastogi
Manuela Rabaglio-Poretti
Julie Lemieux
Alastair M. Thompson
Daniel W. Rea
Vuk Stambolic
Affiliated Authors:
Dawn L. Hershman
Publication Type:
Article
Unique ID:
10.1038/s41523-021-00275-z
Publication Date:
Data Source:
Scopus

Record Created: